Next Article in Journal
Integrative Single-Cell and Machine Learning Analysis Identifies a Nucleotide Metabolism-Related Signature Predicting Prognosis and Immunotherapy Response in LUAD
Previous Article in Journal
15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study
 
 
Article

Article Versions Notes

Cancers 2026, 18(1), 161; https://doi.org/10.3390/cancers18010161
Action Date Notes Link
article pdf uploaded. 2 January 2026 10:16 CET Version of Record https://www.mdpi.com/2072-6694/18/1/161/pdf
Back to TopTop